Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2016 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Improving response inhibition in Parkinson's disease with atomoxetine.
Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Ye Z, et al. Biol Psychiatry. 2015 Apr 15;77(8):740-8. doi: 10.1016/j.biopsych.2014.01.024. Epub 2014 Feb 7. Biol Psychiatry. 2015. PMID: 24655598 Free PMC article. Clinical Trial.
Atomoxetine restores the response inhibition network in Parkinson's disease.
Rae CL, Nombela C, Rodríguez PV, Ye Z, Hughes LE, Jones PS, Ham T, Rittman T, Coyle-Gilchrist I, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Rae CL, et al. Brain. 2016 Aug;139(Pt 8):2235-48. doi: 10.1093/brain/aww138. Epub 2016 Jun 24. Brain. 2016. PMID: 27343257 Free PMC article. Clinical Trial.
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease.
Borchert RJ, Rittman T, Passamonti L, Ye Z, Sami S, Jones SP, Nombela C, Vázquez Rodríguez P, Vatansever D, Rae CL, Hughes LE, Robbins TW, Rowe JB. Borchert RJ, et al. Neuropsychopharmacology. 2016 Jul;41(8):2171-7. doi: 10.1038/npp.2016.18. Epub 2016 Feb 3. Neuropsychopharmacology. 2016. PMID: 26837463 Free PMC article.
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
Ye Z, Rae CL, Nombela C, Ham T, Rittman T, Jones PS, Rodríguez PV, Coyle-Gilchrist I, Regenthal R, Altena E, Housden CR, Maxwell H, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Ye Z, et al. Hum Brain Mapp. 2016 Mar;37(3):1026-37. doi: 10.1002/hbm.23087. Epub 2016 Jan 12. Hum Brain Mapp. 2016. PMID: 26757216 Free PMC article. Clinical Trial.